Albany, New York, Sept. 22, 2014 (GLOBE NEWSWIRE) -- The global companion diagnostics market will be valued at $5.6
billion in 2019. It is expected to grow at a CAGR of 18.1% from
2013 to 2019, and was valued at $1.8 billion in 2013, according to
a research report published by Transparency Market Research.
SAN LUIS OBISPO, Calif., Sept. 22, 2014 (GLOBE NEWSWIRE) -- via PRWEB - SpendSmart Networks, Inc. (OTC:SSPC) ("SpendSmart" or "the Company"), a provider of digital customer loyalty systems and services, today announced that it acquired the eCommerce Solutions division of TechXpress, Inc., also based in San Luis Obispo, CA, for a combination of stock and cash equal to a purchase price of $1.2 million.
OKLAHOMA CITY, Sept. 22, 2014 (GLOBE NEWSWIRE) -- Chaparral Energy, LLC has appointed John D. Wehrle to the role of senior vice president of business development and finance, and David R. Winchester to the role of senior vice president of drilling operations. Wehrle previously served as managing director and co-head of U.S. operations for Scotia Waterous and most recently as a consultant for Apollo Global Management's Natural Resources group. Winchester was most recently with Chesapeake Energy Corporation, where he served as vice president of drilling operations. Wehrle and Winchester will both report to President and Chief Operating Officer Earl Reynolds.
REDWOOD CITY, Calif., Sept. 22, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the appointment of Kathleen Sereda Glaub to its board of directors. Ms. Glaub's 30-year career in leadership positions with drug development and technology companies will bring strong company-building and business strategy experience to the Codexis board.
ATLANTA, Sept. 22, 2014 (GLOBE NEWSWIRE) -- State Bank Financial Corporation (Nasdaq:STBZ) announced today that all regulatory approvals for its proposed merger with Atlanta Bancorporation, Inc. have been received. The transaction was announced on April 28, 2014, and approved by shareholders of Atlanta Bancorporation on June 25, 2014.
TEL AVIV, Israel, Sept. 22, 2014 (GLOBE NEWSWIRE) -- Bio Blast Pharma Ltd (Nasdaq:ORPN), a clinical-stage biotechnology company committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases, announced today it has received Health Canada approval to begin enrolling patients at the Montreal Neurological Institute at McGill University for its HOPEMD Phase 2/3 study investigating Cabaletta in patients with Occulopharyngeal Muscular Dystrophy (OPMD). Professor Bernard Brais, co-director of the neuromuscular group of the Montreal Neurological Institute and Hospital, is the principal investigator of the study in Canada.
WINSTON-SALEM, N.C., Sept. 22, 2014 (GLOBE NEWSWIRE) -- Tengion, Inc. (OTCQB:TNGN), a leader in regenerative medicine, today announced that the Company, with the support of its Board of Directors, is exploring all strategic options to maximize the value of its assets and has retained Jefferies LLC as exclusive financial advisor to assist it with reviewing and structuring potential strategic transactions.
GlobeNewswire, a NASDAQ OMX company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.